Eric Lefebvre
Chief Medical Officer at Pliant Therapeutics, Inc. (PLRX)
Eric Lefebvre has filed 23 insider reports with the SEC since January 2021, as chief Medical Officer at Pliant Therapeutics, Inc. (PLRX) and director at CymaBay Therapeutics, Inc. (CBAY). Eric Lefebvre made no open-market purchases or sales in the last 12 months. The latest filing, on January 27, 2025, reports grant or award at Pliant Therapeutics, Inc. (PLRX).
- Filings
- 23
- Companies
- 2
- Bought on market
- None
- Sold on market
- $4.68M
Companies where Eric Lefebvre is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Chief Medical Officer | 240,224 | $4.68M | $0.5951 | Jan 27, 2025 | |||
| Directorsince March 2022 | Mar 22, 2024 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Jan 23, 2025PLRXChief Medical Officer Lefebvre Eric was granted 45,650 shares, increasing direct ownership by 23% to 240,224 unitsForm 4Grant or award
- Jan 17, 2025-$207KPLRXChief Medical Officer Lefebvre Eric sold $206,974 worth of shares (18,478 units at $11.20), decreasing direct ownership by 9% to 194,574 unitsForm 4Open-market sale10b5-1 plan
- Jul 10, 2024-$142KPLRXChief Medical Officer Lefebvre Eric sold $142,408 worth of shares (12,319 units at $11.56), decreasing direct ownership by 5% to 213,052 unitsForm 4Open-market sale10b5-1 plan
- Jul 9, 2024PLRXChief Medical Officer Lefebvre Eric was granted 24,063 shares, increasing direct ownership by 12% to 225,371 unitsForm 4Grant or award
- Mar 22, 2024CBAYSEC Form 4 filed by Lefebvre EricForm 4Sale back to the company
- Jan 24, 2024CBAYSEC Form 4 filed by Lefebvre EricForm 4Grant or award
- Jan 23, 2024PLRXLefebvre Eric was granted 42,900 shares, increasing direct ownership by 27% to 199,820 unitsForm 4Grant or award
- Jan 17, 2024-$177KPLRXLefebvre Eric sold $177,383 worth of shares (10,295 units at $17.23), decreasing direct ownership by 6% to 156,920 unitsForm 4Open-market sale10b5-1 plan
- Jul 17, 2023-$402KPLRXSEC Form 4 filed by Lefebvre EricForm 4Open-market sale10b5-1 plan
- Jul 14, 2023PLRXSEC Form 4 filed by Lefebvre EricForm 4Grant or award
- Mar 30, 2023-$298KPLRXSEC Form 4 filed by Lefebvre EricForm 4Open-market sale10b5-1 plan
- Mar 29, 2023PLRXSEC Form 4 filed by Lefebvre EricForm 4Grant or award
- Jan 25, 2023PLRXSEC Form 4: Lefebvre Eric was granted 57,000 shares, increasing direct ownership by 74% to 133,926 unitsForm 4Grant or award
- Jan 25, 2023CBAYSEC Form 4 filed by Lefebvre EricForm 4Grant or award
- Jan 23, 2023-$2.33MPLRXSEC Form 4: Lefebvre Eric sold $2,327,630 worth of shares (67,500 units at $34.48) as part of a pre-agreed trading plan, decreasing direct ownership by 47% to 76,926 unitsForm 4Open-market sale10b5-1 plan
- Dec 20, 2022-$208KPLRXSEC Form 4: Lefebvre Eric was granted 21,876 shares and sold $207,968 worth of shares (10,887 units at $19.10), increasing direct ownership by 8% to 144,426 units to satisfy withholding obligationForm 4Grant or awardOpen-market sale
- Jul 11, 2022-$60KPLRXSEC Form 4: Lefebvre Eric sold $60,000 worth of shares (3,000 units at $20.00) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 138,436 unitsForm 4Open-market sale10b5-1 plan
- Mar 21, 2022CBAYSEC Form 4 filed by Lefebvre EricForm 4Grant or award
- Mar 21, 2022CBAYEric Lefebvre became an insiderForm 3New insider
- Jan 26, 2022PLRXSEC Form 4 filed by Lefebvre EricForm 4Grant or award
- Jun 18, 2021-$361KPLRXSEC Form 4: Lefebvre Eric sold $360,821 worth of Common Stock (12,500 units at $28.87), decreasing direct ownership by 8% to 137,080 unitsForm 4Open-market sale10b5-1 plan
- Mar 18, 2021-$493KPLRXSEC Form 4: Eric Lefebvre sold $492,678 worth of Common Stock (12,500 units at $39.41), decreasing direct ownership by 8% to 149,580 unitsForm 4Open-market sale10b5-1 plan
- Jan 23, 2021PLRXSEC Form 4 filed by Eric LefebvreForm 4Grant or award
Compare Eric Lefebvre with
- Eric Lefebvre vs David Raben1 shared
- Eric Lefebvre vs Robert Iannone1 shared
- Eric Lefebvre vs Flavia Borellini1 shared
- Eric Lefebvre vs Thomas A Mccourt1 shared
- Eric Lefebvre vs Gayle A Crowell1 shared
- Eric Lefebvre vs Steve E. Krognes1 shared
Other insiders at the same companies
- David RabenPLRX
- Robert IannonePLRX
- Flavia BorelliniPLRX
- Thomas A MccourtPLRX
- Gayle A CrowellPLRX
- Hoyoung HuhPLRX
- Steve E. KrognesPLRX
- John T CurnuttePLRX
- Darren S ClinePLRX
- Minnie KuoPLRX
- Bernard CouliePLRX
- Keith Lamont CummingsPLRX
- Lily CheungPLRX
- Suzanne Louise BruhnPLRX
- Katharine KnobilPLRX
- Pyott David E IPLRX
Questions about Eric Lefebvre
- What is Eric Lefebvre's role at Pliant Therapeutics, Inc.?
- Eric Lefebvre reports to the SEC as chief Medical Officer at Pliant Therapeutics, Inc. (PLRX), according to the latest filing on January 27, 2025. Eric Lefebvre has also filed as director at CymaBay Therapeutics, Inc. (CBAY).
- How many shares does Eric Lefebvre own?
- After the latest filing that states it, Eric Lefebvre directly owned 240,224 shares of Pliant Therapeutics, Inc. (PLRX). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Eric Lefebvre bought or sold stock recently?
- The most recent open-market sale was on January 17, 2025: sold 18,478 shares of Pliant Therapeutics, Inc. (PLRX) for $207K at an average of $11.20.
- How do I get alerts when Eric Lefebvre files?
- Follow Eric Lefebvre on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Eric Lefebvre (SEC CIK 0001614741). Totals count each trade once, skipping amendments whose original is on file, from Jan 27, 2021 on. View on SEC EDGAR · Get this as JSON